Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Cipro	O
/	O
Cardura	O
/	O
Codeine	O
/	O
Bactrim	O
Ds	O
/	O
Augmentin	O
/	O
Alendronate	O
Sodium	O
/	O
Imuran	O
Attending:	O
___.	O
Chief	O
Complaint:	O
bacteremia	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
none	O
History	O
of	O
Present	O
Illness:	O
Mrs	O
___	O
is	O
a	O
pleasant	O
___	O
year	O
old	O
female	O
with	O
p-ANCA	O
vasculitis	O
on	O
high-dose	O
steroids	O
and	O
MTX	O
who	O
developed	O
high-grade	O
fevers	O
to	O
103.9,	O
found	O
to	O
have	O
bacteremia	O
with	O
GNR	O
in	O
___	O
bottles	O
when	O
seen	O
in	O
___	O
clinic	O
on	O
___,	O
pt	O
was	O
called	O
and	O
instructed	O
to	O
go	O
to	O
ED	O
when	O
cxs	O
returned	O
positive	O
on	O
___.	O
Pt	O
states	O
she	O
has	O
been	O
asymptomatic	O
except	O
for	O
one	O
episode	O
of	O
vomiting	O
two	O
nights	O
prior	O
to	O
admission	O
and	O
general	O
fatigue	O
over	O
the	O
past	O
week.	O
Denies	O
recent	O
wt	B-Weight_loss
loss,	B-Weight_loss
cough,	O
CP,	O
SOB,	O
dysuria,	O
blood	O
in	O
urine.	O
She	O
stated	O
that	O
she	O
is	O
very	O
occasionally	O
incontinent	B-Urinary_incontinence
of	B-Urinary_incontinence
urine	B-Urinary_incontinence
at	O
baseline.	O
Of	O
note,	O
pt	O
states	O
she	O
has	O
also	O
noticed	O
LUE	O
and	O
LLE	O
weakness	O
over	O
the	O
past	O
week,	O
no	O
aphasia	O
or	O
slurred	O
speech.	O
.	O
In	O
the	O
ED,	O
initial	O
vs	O
were:	O
100,	O
120/50,	O
97%	O
on	O
RA.	O
Patient	O
was	O
given	O
meropenem	O
given	O
hx	O
of	O
enterobacter	O
in	O
urine	O
sensitive	O
to	O
meropenem.	O
.	O
On	O
the	O
floor,	O
pt	O
feels	O
generally	O
well.	O
No	O
current	O
N/V/D/CP/SOB.	O
Past	O
Medical	O
History:	O
*	O
pANCA	O
vasculitis:	O
Wegener's'	O
granulomatosis	O
versus	O
microscopic	O
polyangiitis;	O
w/	O
crescentic	O
glomerulonephritis,	O
acute	O
renal	O
failure,	O
rx	O
cytoxan	O
and	O
prednisone;	O
dx	O
___	O
hx	O
of	O
renal-pulmonary	O
syndrome	O
*	O
MGUS	O
(IgG	O
lambda)	O
*	O
CAD-	O
c.	O
cath	O
in	O
___	O
with	O
RCA	O
stent,	O
no	O
other	O
disease,	O
EF	O
55%	O
*	O
DMII	O
(diet	O
controlled)	O
*	O
HTN	O
*	O
Hypothyroidism	O
*	O
ILD,	O
followed	O
by	O
Dr.	O
___	O
*	O
Pulmonary	O
nodule,	O
RML	O
*	O
colon	O
perforation	O
following	O
colonoscopy	O
*	O
SVT	O
*	O
GERD	O
*	O
Gastritis	O
*	O
Hyperlipidemia	O
*	O
Abnormal	O
___	O
(stable,	O
microcalcs)	O
*	O
Adrenal	O
Adenoma	O
(Neg	O
w/u	O
___,	O
stable	O
f/u)	O
*	O
Osteopenia	O
*	O
Sensineural	O
hearing	B-Hearing_impairment
loss	B-Hearing_impairment
b/l,	O
also	O
s/p	O
R	O
TM	O
fungal	O
infxn	O
*	O
Recent	O
bacterial	O
sinusitis	O
in	O
___	O
*	O
Pneumonia	B-Lower_respiratory_tract_infection
___	O
*	O
Chronic	O
Anemia	O
*	O
Hx	O
of	O
total	O
abdominal	O
hystorectomy	O
*	O
Hx	O
of	O
cholecystectomy	O
*	O
Hx	O
of	O
stress	O
urinary	B-Urinary_incontinence
incontinence	B-Urinary_incontinence
Social	O
History:	O
___	O
Family	O
History:	O
Father	O
died	O
at	O
___	O
from	O
an	O
MI;	O
mother	O
had	O
a	O
stroke	O
at	O
___.	O
Brother	O
with	O
leukemia.	O
Also	O
with	O
hx	O
of	O
lung	O
cancer	O
in	O
family.	O
Physical	O
Exam:	O
On	O
Admission:	O
.	O
Vitals:	O
T:98	O
BP:116/60	O
P:76	O
R:12	O
O2:97%	O
RA	O
General:	O
Alert,	O
oriented,	B-Delirium
no	O
acute	O
distress	O
HEENT:	O
Sclera	O
anicteric,	O
MMM,	O
oropharynx	O
clear	O
Neck:	O
supple,	O
JVP	O
at	O
7	O
CM,	O
no	O
LAD,	O
no	O
carotid	O
bruits	O
Lungs:	O
Crackles	O
throughout,	O
loudest	O
at	O
bases	O
CV:	O
Regular	O
rate	O
and	O
rhythm,	O
normal	O
S1	O
+	O
S2,	O
___	O
SEM,	O
rubs,	O
gallops	O
Abdomen:	O
soft,	O
non-tender,	O
non-distended,	O
bowel	O
sounds	O
present,	O
no	O
rebound	O
tenderness	O
or	O
guarding,	O
no	O
organomegaly	O
GU:	O
no	O
foley	O
Ext:	O
warm,	O
well	O
perfused,	O
2+	O
pulses,	O
no	O
clubbing,	O
cyanosis.	O
2+	O
bilat	O
___	O
edema	O
to	O
knees.	O
LLE	O
edema	O
worse	O
than	O
RLE	O
edema.	O
NEURO:	O
CNs	O
___	O
intact.	O
___	O
strength	O
in	O
LUE	O
and	O
left	O
hip	O
flexors,	O
___	O
strengh	O
on	O
R	O
side.	O
1+	O
bilat	O
biceps	O
reflexes,	O
2+	O
bilat	O
patellar.	O
.	O
Pertinent	O
Results:	O
On	O
admission:	O
.	O
___	O
11:25AM	O
BLOOD	O
WBC-6.7	O
RBC-2.51*	O
Hgb-8.9*	O
Hct-26.5*	O
MCV-105*	O
MCH-35.3*	O
MCHC-33.5	O
RDW-14.7	O
Plt	O
___	O
___	O
11:25AM	O
BLOOD	O
Neuts-88*	O
Bands-3	O
Lymphs-3*	O
Monos-4	O
Eos-1	O
Baso-0	O
___	O
Myelos-1*	O
NRBC-1*	O
___	O
11:25AM	O
BLOOD	O
Hypochr-NORMAL	O
Anisocy-NORMAL	O
Poiklo-1+	O
Macrocy-3+	O
Microcy-NORMAL	O
Polychr-NORMAL	O
Tear	O
Dr-1+	O
___	O
11:25AM	O
BLOOD	O
Plt	O
Smr-NORMAL	O
Plt	O
___	O
___	O
11:25AM	O
BLOOD	O
ESR-95*	O
___	O
11:25AM	O
BLOOD	O
UreaN-57*	O
Creat-2.2*	O
Na-140	O
K-4.6	O
Cl-103	O
HCO3-24	O
AnGap-18	O
___	O
11:25AM	O
BLOOD	O
ALT-57*	O
AST-24	O
CK(CPK)-30	O
AlkPhos-61	O
___	O
11:25AM	O
BLOOD	O
Albumin-3.6	O
Calcium-9.4	O
Phos-2.9	O
Mg-1.9	O
___	O
11:25AM	O
BLOOD	O
ANCA-NEGATIVE	O
B	O
___	O
11:25AM	O
BLOOD	O
CRP-157.5*	O
___	O
12:22PM	O
BLOOD	O
Lactate-1.8	O
___	O
02:00PM	O
URINE	O
___	O
Bacteri-FEW	O
Yeast-NONE	O
___	O
___	O
11:25	O
am	O
BLOOD	O
CULTURE	O
Blood	O
Culture,	O
Routine	O
(Preliminary):	O
KLEBSIELLA	O
PNEUMONIAE.	O
FINAL	O
SENSITIVITIES.	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
_________________________________________________________	O
KLEBSIELLA	O
PNEUMONIAE	O
|	O
AMPICILLIN/SULBACTAM--	O
4	O
S	O
CEFAZOLIN-------------	O
<=4	O
S	O
CEFEPIME--------------	O
<=1	O
S	O
CEFTAZIDIME-----------	O
<=1	O
S	O
CEFTRIAXONE-----------	O
<=1	O
S	O
CIPROFLOXACIN---------<=0.25	O
S	O
GENTAMICIN------------	O
<=1	O
S	O
MEROPENEM-------------<=0.25	O
S	O
PIPERACILLIN/TAZO-----	O
<=4	O
S	O
TOBRAMYCIN------------	O
<=1	O
S	O
TRIMETHOPRIM/SULFA----	O
=>16	O
R	O
.	O
Imaging:	O
___	O
CXR:	O
IMPRESSION:	O
No	O
acute	O
findings.	O
Chronic	O
interstitial	O
lung	O
disease	O
redemonstrated.	O
Stable	O
cardiomegaly.	O
.	O
___:	O
dry	O
CT	B-Intracranial_haemorrhage
head	B-Intracranial_haemorrhage
IMPRESSION:	O
No	O
acute	O
intracranial	B-Intracranial_haemorrhage
process.	O
Sequelae	O
of	O
chronic	O
microvascular	O
disease,	O
and	O
atrophy.	O
___:	O
LLE	O
Ultrasound	O
-	O
netgative	O
for	O
DVT	O
___	O
06:20AM	O
BLOOD	O
WBC-6.6	O
RBC-2.25*	O
Hgb-8.5*	O
Hct-24.6*	O
MCV-109*	O
MCH-37.5*	O
MCHC-34.3	O
RDW-16.0*	O
Plt	O
___	O
___	O
06:25AM	O
BLOOD	O
WBC-9.1	O
RBC-2.25*	O
Hgb-7.9*	O
Hct-23.3*	O
MCV-104*	O
MCH-35.1*	O
MCHC-33.9	O
RDW-15.9*	O
Plt	O
___	O
___	O
06:25AM	O
BLOOD	O
___	O
PTT-20.6*	O
___	O
___	O
07:00AM	O
BLOOD	O
___	O
___	O
11:25AM	O
BLOOD	O
ESR-95*	O
___	O
06:25AM	O
BLOOD	O
Glucose-126*	O
UreaN-50*	O
Creat-1.7*	O
Na-140	O
K-4.1	O
Cl-104	O
HCO3-26	O
AnGap-14	O
___	O
06:20AM	O
BLOOD	O
calTIBC-199*	O
VitB12-186*	O
Folate-15.2	O
Ferritn-1280*	O
TRF-153*	O
___	O
12:44PM	O
BLOOD	O
Homocys-22.0*	O
___	O
12:44PM	O
BLOOD	O
METHYLMALONIC	O
ACID-PND	O
Brief	O
Hospital	O
Course:	O
___	O
year	O
old	O
female	O
with	O
p-ANCA	O
vasculitis	O
on	O
high-dose	O
immunosuppression	O
who	O
developed	O
Klebsiella	O
pneumo	O
UTI	B-Urinary_tract_infection
and	O
subsequent	O
bacteremia.	O
She	O
was	O
admitted	O
for	O
IV	O
antibiotics,	O
her	O
chills	O
improved,	O
and	O
when	O
surveillance	O
cultures	O
were	O
negative	O
she	O
was	O
sent	O
home	O
on	O
PO	O
antibiotics.	O
She	O
remained	O
afebrile	O
and	O
without	O
leukocytosis;	O
she	O
will	O
follow	O
up	O
with	O
her	O
PCP	O
and	O
rheumatologist.	O
#	O
Bacteremia:	O
from	O
Klebsiella	O
pneumo	O
UTI	B-Urinary_tract_infection
Lactate	O
WNL,	O
no	O
hemodynamic	O
instability	O
to	O
support	O
septic	O
physiology.	O
Pt	O
at	O
increased	O
risk	O
for	O
infx	O
given	O
that	O
she	O
is	O
on	O
multiple	O
immunosuppressive	O
medications	O
for	O
her	O
vasculitis.	O
-She	O
received	O
meropenem	O
in	O
the	O
ER,	O
which	O
was	O
switched	O
to	O
Cefepime	O
after	O
Sensitivities	O
returned.	O
She	O
was	O
treated	O
for	O
3	O
days	O
with	O
IV	O
antibiotics	O
and	O
then	O
she	O
was	O
sent	O
home	O
on	O
PO	O
Cefpodoxime	O
x11	O
days	O
(total	O
antibiotic	O
Rx	O
14	O
days)	O
.	O
#	O
New	O
L-sided	O
weakness	O
for	O
the	O
past	O
week:	O
Left	O
arm	O
and	O
leg,	O
was	O
concerning	O
for	O
stroke.	O
Also	O
with	O
LUE	O
pain	O
which	O
could	O
be	O
contributing.	O
Dry	O
head	O
CT	O
negative.	O
-Neuro	O
consult:	O
no	O
evidence	O
of	O
stroke;	O
likely	O
limited	O
mobility	O
secondary	O
to	O
pain.	O
.	O
#	O
Elevated	O
creatinine:	O
at	O
baseline	O
throughout	O
the	O
admission.	O
Meds	O
were	O
renally	O
dosed.	O
.	O
#	O
Anemia:	O
Macrocytic	O
and	O
Microcytic	O
-	O
Iron	O
studies	O
revealed	O
anemia	O
of	O
chronic	O
disease,	O
and	O
also	O
patient	O
found	O
to	O
be	O
B12	O
deficient	O
(186)	O
and	O
folate	O
deficient	O
-Patient	O
started	O
on	O
B12,	O
folate	O
-was	O
transfused	O
1	O
unit	O
prior	O
to	O
d/c	O
because	O
of	O
hct	O
23.3	O
considering	O
cardiac	O
history	O
-	O
homocysteine	O
and	O
MMA	O
levels	O
are	O
pending	O
at	O
the	O
time	O
of	O
discharge	O
.	O
#	O
Vasculitis:	O
on	O
immunosupressants.	O
Pulm	O
status	O
currently	O
stable,	O
however	O
crackles	O
likely	O
___	O
chronic	O
lung	O
disease.	O
Per	O
rheumatology,	O
she	O
was	O
continued	O
on	O
prednisone	O
at	O
15	O
mg	O
q	O
day,	O
methotrexate/leukovorin	O
were	O
held.	O
She	O
was	O
continued	O
on	O
bactrim	O
prophylaxis	O
while	O
in	O
house.	O
She	O
was	O
discharged	O
on	O
the	O
above	O
regimen	O
until	O
follow	O
up	O
with	O
rheum	O
as	O
an	O
outpatient.	O
.	O
#	O
Hx	O
hypertension:	O
resonably	O
controlled	O
this	O
admission.	O
She	O
was	O
continued	O
on	O
amlodipine,	O
lisinopril,	O
metoprolol,	O
and	O
Clonidine	O
patch.	O
.	O
#	O
HLD:	O
continued	O
on	O
home	O
statin	O
.	O
#	O
GERD:	O
continued	O
on	O
home	O
PPI	O
.	O
#	O
Hypothyroidism:	O
continued	O
on	O
home	O
levothyroxine	O
Medications	O
on	O
Admission:	O
Amlodipine	O
10	O
mg	O
Tablet	O
Clonidine	O
[Catapres-TTS-2]	O
0.2	O
mg/24	O
hour	O
Patch	O
Weekly	O
Ergocalciferol	O
(Vitamin	O
D2)	O
[Vitamin	O
D]	O
50,000	O
unit	O
Capsule	O
Furosemide	O
40	O
mg	O
Tablet	O
Leucovorin	O
Calcium	O
5	O
mg	O
Tablet	O
Levothyroxine	O
[Synthroid]	O
50	O
mcg	O
Tablet	O
Lidocaine	O
HCl	O
[Lidocaine	O
Viscous]	O
20	O
mg/mL	O
Solution	O
rinse	O
mouth	O
four	O
times	O
a	O
day	O
as	O
needed	O
for	O
mouth	O
soreness	O
___	O
Lisinopril	O
10	O
mg	O
Tablet	O
Methotrexate	O
Sodium	O
[Methotrexate	O
(Anti-Rheumatic)]	O
15	O
mg	O
by	O
mouth	O
weekly	O
___	O
Metoprolol	O
Succinate	O
25	O
mg	O
Tablet	O
Sustained	O
Release	O
24	O
hr	O
Pantoprazole	O
[Protonix]	O
40	O
mg	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
Prednisone	O
15	O
mg	O
Tablet	O
by	O
mouth	O
every	O
morning	O
with	O
breakfast	O
Simvastatin	O
40	O
mg	O
Tablet	O
Sulfamethoxazole-Trimethoprim	O
400	O
mg-80	O
mg	O
Tablet	O
Acetaminophen	O
[Tylenol	O
Extra	O
Strength]	O
Aspirin	O
81	O
mg	O
Tablet	O
Calcium	O
Carbonate-Vitamin	O
D3	O
[Caltrate-600	O
Plus	O
Vitamin	O
D3]	O
600	O
mg-400	O
unit	O
Tablet	O
Docusate	O
Sodium	O
[Colace]	O
100	O
mg	O
Capsule	O
Discharge	O
Medications:	O
1.	O
Amlodipine	O
5	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
2.	O
Clonidine	O
0.2	O
mg/24	O
hr	O
Patch	O
Weekly	O
Sig:	O
One	O
(1)	O
Patch	O
Weekly	O
Transdermal	O
once	O
a	O
week.	O
3.	O
Ergocalciferol	O
(Vitamin	O
D2)	O
50,000	O
unit	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
every	O
other	O
week.	O
4.	O
Levothyroxine	O
50	O
mcg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
5.	O
Lidocaine	O
Viscous	O
2	O
%	O
Solution	O
Sig:	O
One	O
(1)	O
rinse	O
Mucous	O
membrane	O
four	O
times	O
a	O
day	O
as	O
needed	O
for	O
mouth	O
soreness.	O
6.	O
Lisinopril	O
10	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
7.	O
Metoprolol	O
Succinate	O
25	O
mg	O
Tablet	O
Sustained	O
Release	O
24	O
hr	O
Sig:	O
One	O
(1)	O
Tablet	O
Sustained	O
Release	O
24	O
hr	O
PO	O
once	O
a	O
day.	O
8.	O
Pantoprazole	O
40	O
mg	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
Sig:	O
One	O
(1)	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
PO	O
Q24H	O
(every	O
24	O
hours).	O
9.	O
Prednisone	O
5	O
mg	O
Tablet	O
Sig:	O
Three	O
(3)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
10.	O
Simvastatin	O
40	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
11.	O
Sulfamethoxazole-Trimethoprim	O
400-80	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
12.	O
Acetaminophen	O
325	O
mg	O
Tablet	O
Sig:	O
___	O
Tablets	O
PO	O
every	O
___	O
hours	O
as	O
needed	O
for	O
fever	O
or	O
pain.	O
13.	O
Aspirin	O
81	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day.	O
14.	O
Calcium	O
Carbonate-Vitamin	O
D3	O
600-400	O
mg-unit	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
twice	O
a	O
day:	O
with	O
food.	O
15.	O
Docusate	O
Sodium	O
100	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
16.	O
Folic	O
Acid	O
1	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
Disp:*30	O
Tablet(s)*	O
Refills:*2*	O
17.	O
Cyanocobalamin	O
100	O
mcg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
Disp:*30	O
Tablet(s)*	O
Refills:*2*	O
18.	O
Furosemide	O
40	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day.	O
19.	O
Cefpodoxime	O
200	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day	O
for	O
11	O
days:	O
11	O
more	O
days	O
(total	O
of	O
14).	O
Disp:*11	O
Tablet(s)*	O
Refills:*0*	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection	B-Urinary_tract_infection
/	O
bacteremia	O
Discharge	O
Condition:	O
Patient	O
is	O
being	O
discharged	O
to	O
her	O
home;	O
she	O
is	O
ambulating	O
without	O
difficulty	O
and	O
she	O
is	O
alert/oriented.	O
Discharge	O
Instructions:	O
You	O
were	O
admitted	O
to	O
the	O
hospital	O
because	O
blood	O
drawn	O
at	O
your	O
outpatient	O
Rheumatology	O
appointment	O
came	O
back	O
positive	O
for	O
bacteria.	O
You	O
had	O
a	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection,	B-Urinary_tract_infection
and	O
the	O
bacteria	O
from	O
there	O
went	O
into	O
your	O
bloodstream.	O
We	O
treated	O
you	O
with	O
intravenous	O
antibiotics	O
for	O
a	O
few	O
days,	O
and	O
when	O
you	O
improved	O
we	O
sent	O
you	O
home	O
with	O
11	O
days	O
of	O
oral	O
antibiotics.	O
You	O
also	O
received	O
one	O
unit	O
of	O
blood	O
to	O
help	O
with	O
your	O
chronic	O
anemia.	O
***It	O
is	O
VERY	O
important	O
that	O
you	O
take	O
ALL	O
the	O
antibiotic	O
Cefpodoxime	O
pills	O
(until	O
they	O
are	O
finished)	O
even	O
if	O
you	O
feel	O
better.	O
In	O
addition,	O
we	O
started	O
new	O
vitamins,	O
folate	O
and	O
Vitamin	O
B12,	O
because	O
your	O
levels	O
were	O
low.	O
Please	O
follow	O
up	O
with	O
your	O
PCP	O
and	O
rheumatologist.	O
The	O
following	O
changes	O
were	O
made	O
to	O
your	O
medications:	O
-Started	O
cefpodoxime	O
for	O
your	O
infection	O
(11	O
more	O
days)	O
-Vitmain	O
B12	O
and	O
folate	O
were	O
started	O
for	O
your	O
vitamin	O
defiencies	O
-Your	O
Prednisone	O
was	O
kept	O
at	O
15mg	O
-Please	O
stop	O
taking	O
the	O
Methotrexate	O
and	O
Leucovorin	O
until	O
follow	O
up	O
with	O
your	O
Rheumatologist	O
Followup	O
Instructions:	O
___	O

